A 32-year-old multiparous woman at 26 weeks gestation is found to have gestational diabetes on OGTT (2-hour value 168 mg/dL). Her antenatal records show a prior macrosomic infant (birth weight 4.2 kg) and a history of polycystic ovary syndrome. Which maternal metabolic finding best distinguishes women with GDM who will have adverse fetal outcomes from those with uncomplicated pregnancies?

Explanation

## Metabolic Predictors of Adverse Outcomes in GDM ### The Role of Postprandial Hyperglycemia **Key Point:** In GDM, the *1-hour postprandial glucose* on OGTT is the single strongest predictor of fetal hyperinsulinemia, macrosomia, and neonatal hypoglycemia. A 1-hour value >180 mg/dL identifies women at highest risk of adverse perinatal outcomes. ### Evidence-Based Risk Stratification | Glucose Threshold | Clinical Significance | Fetal/Neonatal Risk | | --- | --- | --- | | **1-hour OGTT >180 mg/dL** | Indicates severe postprandial spike | High risk of macrosomia, shoulder dystocia, neonatal hypoglycemia | | **1-hour OGTT 140–180 mg/dL** | Moderate postprandial hyperglycemia | Intermediate risk; requires glycemic control | | **1-hour OGTT <140 mg/dL** | Normal postprandial response | Low risk of fetal hyperinsulinemia | | **Fasting glucose >95 mg/dL** | Reflects baseline hyperglycemia | Associated with increased risk but less predictive than 1-hour value | | **2-hour glucose >155 mg/dL** | Delayed glucose clearance | Moderate predictor; less specific than 1-hour | ### Pathophysiology: Why 1-Hour Glucose Matters **High-Yield:** Maternal postprandial hyperglycemia (especially the sharp 1-hour spike) crosses the placenta as glucose, stimulating fetal pancreatic β-cell hyperplasia and hyperinsulinemia. Fetal hyperinsulinemia drives: - Increased fetal fat and lean mass deposition → macrosomia - Neonatal hypoglycemia (due to sudden loss of maternal glucose supply at birth) - Increased risk of birth trauma (shoulder dystocia, cephalopelvic disproportion) **Clinical Pearl:** Women with GDM and 1-hour OGTT >180 mg/dL have a macrosomia risk of ~40–50%, compared to ~15–20% in those with 1-hour <140 mg/dL. This is why intensive glycemic control targeting postprandial glucose is emphasized. ### Mnemonic **OGTT Risk Zones — "One Hour Tells All"** - **O**ver 180 at 1 hour → **O**utcomes worst (macrosomia, hypoglycemia) - **G**lucose at 1 hour is the **G**reatest predictor of fetal harm - **T**wo-hour and fasting are **T**oo late to catch the spike - **T**herapy targets postprandial glucose to prevent fetal hyperinsulinemia [cite:Harrison 21e Ch 297; ACOG Practice Bulletin 190]